Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun;23(8):865-868.
doi: 10.1080/14656566.2022.2057795. Epub 2022 Mar 28.

What impact can molnupiravir have on the treatment of SARS-CoV-2 infection?

Affiliations
Editorial

What impact can molnupiravir have on the treatment of SARS-CoV-2 infection?

Fatima Kayali et al. Expert Opin Pharmacother. 2022 Jun.
No abstract available

Keywords: Antivirals; COVID-19; SARS-CoV-2; coronavirus; molnupiravir; pharmacotherapy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The life cycle of the SARS-CoV-2 virus and the mechanism of action of the antivirals. reproduced from [8] with permission of Elsevier.

References

    1. Ludwig S, Zarbock A.. Coronaviruses and SARS-CoV-2: a brief overview. Anesth Analg. 2020;131(1): 93–96. - PMC - PubMed
    1. COVID-19 Dashboard . Johns Hopkins University & Medicine; 2022. [cited 2022 Jan 16. Available from: https://coronavirus.jhu.edu/map.html
    1. Srinivas P, Sacha GL, Koval C. Antivirals for COVID-19. Cleve Clin J Med. 2020. Oct 7. DOI:10.3949/ccjm.87a.ccc030. - DOI - PubMed
    1. Emergency Use Authorization Declaration [Internet] . Federal Register. 2020. [cited 2022 Jan 2]. Available from: https://www.federalregister.gov/documents/2020/04/01/2020-06905/emergenc...
    1. Yadav T, Srivastava N, Mishra G, et al. Recombinant vaccines for COVID-19. Hum Vaccin Immunother. 2020. Nov 24;16:1–8. - PMC - PubMed

Publication types